Sun Pharmaceutical Industries Ltd. News and Updates

Name: Latest research reports of Sun Pharmaceutical Industries Ltd. authored by Hem Securities and published by - Trendlyne research reports.
Item: Sun Pharmaceutical Industries Ltd.
Rating: 3
Author: Hem Securities

Keep track of all breaking news on Sun Pharmaceutical Industries Ltd. from all sources in a single place.

Load latest

Sun Pharmaceutical Industries Ltd.

04 Mar 2020

1578.70

0.86%

Pharma stocks gain for second straight day; Sun Pharma surges 12% in 2 days

Business Standard

According to CARE Ratings, pharma exports from India are estimated to rise by about 11 to 12 per cent on a year on year.

Sun Pharmaceutical Industries Ltd. is trading below all available SMAs

Sun Pharmaceutical Industries Ltd.

04 Mar 2020

1578.70

0.86%

Shanghvi Finance raises stake in Sun Pharma

Economic Times

Shares of Sun Pharma ended up 6.6 per cent at Rs 393.35 on Tuesday.

Sun Pharmaceutical Industries Ltd. is trading below all available SMAs

Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar for short term

Moneycontrol | 04 Mar 2020

Sun Pharmaceutical Industries Ltd.

03 Mar 2020, 11:15AM

1578.70

0.86%

Sun Pharma share price up 3% after Morgan Stanley remains overweight

Moneycontrol

The stock was trading with volumes of 654,539 shares, compared to its five-day average of 422,811 shares, an increase of 54.81 percent.

Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.

Sun Pharmaceutical Industries Ltd.

02 Mar 2020, 08:42PM

1578.70

0.86%

Sun Pharma's hypertension drug in shortage in US due to shortfall in active ingredients

Business Line

Drugmaker Sun Pharmaceutical Industries Ltd reported a shortage of its generic version of hypertension drug pindolol in the US due to a lack of pharm

Sun Pharmaceutical Industries Ltd. is trading below all available SMAs

Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint

NDTV Profit | 02 Mar 2020, 02:22PM 1 more

Sun Pharmaceutical Industries Ltd.

29 Feb 2020

1578.70

0.86%

Coronavirus outbreak: Don't panic over supplies, says pharma industry

Business Standard

Sun Pharma's Dilip Shanghvi said the industry and government were working closely to reduce dependence on one country

Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.

Sun Pharmaceutical Industries Ltd.

26 Feb 2020

1578.70

0.86%

Sun Pharma launches diabetes drug in the US market

Business Line

Sun Pharmaceutical Industries on Wednesday said its wholly-owned subsidiary had launched Riomet ER, used to treat type 2 diabetes mellitus, in the US

Sun Pharmaceutical Industries Ltd. is trading below all available SMAs

Sun Pharmaceutical Industries Ltd.

20 Feb 2020

1578.70

0.86%

Today's picks: From Sun Pharma to BPCL, hot stocks to watch on Thursday

Business Standard

For Sun Pharma, keep a stop at 407 and go short

Sun Pharmaceutical Industries Ltd. is trading below all available SMAs

Sun Pharmaceutical Industries Ltd.

19 Feb 2020

1578.70

0.86%

Sun Pharma, others on regulator's radar as drugs flunk quality tests

livemint

Regulator CDSCO flags 34 samples, including those of Zydus Cadila's pain relief drug, as substandard.Sun Pharmaceutical says it will share its internal test report of the retain samples of the valaciclovir hydrochloride batches with CDSCO to resolve all issues

Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.

Sun Pharmaceutical Industries Ltd.

11 Feb 2020

1578.70

0.86%

Result Review- Sun pharma

Hold: Sun Pharmaceutical Industr...

Hem Securities

Sun Pharmaceutical Industries Ltd is an international specialty pharma company. The company also makes active pharmaceutical ingredients. In branded markets, their products are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, dialectology and respiratory. The company is engaged in manufacturing of product in the following therapy areas: CNS disorders, Cardiology, Diabetes and Metabolic disorders, Gastroenterology, Ophthalmology, Oncology, Pain, Allergy, Asthma...

Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr

Sun Pharmaceutical Industries Ltd.

11 Feb 2020

1578.70

0.86%

Sun Pharma

Results Update: Sun Pharmaceutical Industr...

SMC online

Total revenue from operations for the December quarter stood at Rs 8,154.85 crore, up 5.36% from Rs 7,740.19 crore in Q3 December 2018. Profit before tax declined 21.89% to Rs 1,351.33 crore in Q3 FY20 from Rs 1,730.11 crore in Q3 FY19. In Q3 FY20, EBITDA stood at Rs 1,725 crore with a resulting EBITDA margin of 21.5%. India sales stood at Rs 2,517 crore, growth of 13% over Q3 last year. US finished dosage sales at $ 350 million, decline of 3% over Q3 last year. Emerging markets sales at $195 million, down by 4% Q3 last year. Rest of World sales at $155...